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Abstract
Endothelium-leukocyte interaction is critical for inflammatory responses. Whereas the tissue microenvironments are often
acidic at inflammatory sites, the mechanisms by which cells respond to acidosis are not well understood. Using molecular,
cellular and biochemical approaches, we demonstrate that activation of GPR4, a proton-sensing G protein-coupled receptor,
by isocapnic acidosis increases the adhesiveness of human umbilical vein endothelial cells (HUVECs) that express GPR4
endogenously. Acidosis in combination with GPR4 overexpression further augments HUVEC adhesion with U937
monocytes. In contrast, overexpression of a G protein signaling-defective DRY motif mutant (R115A) of GPR4 does not elicit
any increase of HUVEC adhesion, indicating the requirement of G protein signaling. Downregulation of GPR4 expression by
RNA interference reduces the acidosis-induced HUVEC adhesion. To delineate downstream pathways, we show that
inhibition of adenylate cyclase by inhibitors, 29,59-dideoxyadenosine (DDA) or SQ 22536, attenuates acidosis/GPR4-induced
HUVEC adhesion. Consistently, treatment with a cAMP analog or a Gi signaling inhibitor increases HUVEC adhesiveness,
suggesting a role of the Gs/cAMP signaling in this process. We further show that the cAMP downstream effector Epac is
important for acidosis/GPR4-induced cell adhesion. Moreover, activation of GPR4 by acidosis increases the expression of
vascular adhesion molecules E-selectin, VCAM-1 and ICAM-1, which are functionally involved in acidosis/GPR4-mediated
HUVEC adhesion. Similarly, hypercapnic acidosis can also activate GPR4 to stimulate HUVEC adhesion molecule expression
and adhesiveness. These results suggest that acidosis/GPR4 signaling regulates endothelial cell adhesion mainly through
the Gs/cAMP/Epac pathway and may play a role in the inflammatory response of vascular endothelial cells.
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Introduction
Local or systemic acidosis is associated with a variety of
pathological conditions such as inflammation, ischemia, tumor,
diabetic ketoacidosis, and lung and renal diseases due to defective
blood flow, hypoxia, and glycolytic metabolism [1,2,3,4,5,6]. For
instance, interstitial pH in ischemic organs often decreases to 7.0 -
6.0 and sometimes even below 6.0 [5,7,8]. There are two major
types of acidosis: isocapnic acidosis, such as metabolic acidosis
caused by excessive metabolic acids, and hypercapnic acidosis,
such as respiratory acidosis caused by carbon dioxide accumula-
tion [9,10,11]. Acidosis has profound effects on blood vessels,
immune cells, inflammatory responses, and tissue injury
[4,8,12,13,14,15], but the molecular mechanisms by which
acidosis regulates vascular function, endothelium-leukocyte inter-
action and inflammation are not well known.
The GPR4 family of proton-sensing G protein-coupled
receptors (GPCRs) has recently been identified as novel pH
sensors [15,16,17,18,19,20,21]. GPR4, originally cloned as an
orphan GPCR, is expressed in a wide range of tissues such as the
lung, kidney, heart, and liver [22,23,24]. GPR4 is highly
conserved during evolution, with more than 90% amino acid
sequence homology among mammalian orthologs and more than
70% homology between human and zebrafish orthologs. Howev-
er, the biological function of GPR4 is not clearly defined. GPR4
was previously reported as a receptor for sphingosylphosphor-
ylcholine (SPC) and lysophosphatidylcholine (LPC) [25], but this
observation has not always been confirmed [20,26,27] and the
original publication has been withdrawn [25]. Several studies
indicated that GPR4 mediates the SPC-induced endothelial tube
formation, LPC-induced impairment of endothelial barrier
function, and LPC-induced vascular cell adhesion molecule-1
(VCAM-1) expression [28,29,30]. Since the ligand-receptor
relationship between SPC, LPC and GPR4 is not validated, it is
unclear whether GPR4 directly or indirectly mediates the
biological effects of SPC and LPC.
More recent studies from several research groups demonstrated
that GPR4 predominantly functions as a proton sensor activated
by extracellular acidic pH [15,16,17,20]. Protonation of several
extracellular histidine residues of GPR4 is important for the
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receptor activation [16,17]. GPR4, together with OGR1, TDAG8
and G2A, comprise a novel proton-sensing GPCR family
[15,16,17,18,19,20,21]. We have recently shown that activation
of GPR4 by acidosis stimulates the Gs/cyclic adenosine mono-
phosphate (cAMP) signaling in endothelial cells and regulates
microvessel growth [15]. GPR4-null neonatal mice exhibit a
partially penetrant phenotype of spontaneous hemorrhaging with
small blood vessel defects [15]. Recent analysis of GPR4-null mice
has revealed that GPR4 is involved in acid-base homeostasis in the
kidney [31]. These data suggest that GPR4 is a functional proton
sensor in cells.
GPR4 can be stimulated by extracellular acidic pH to transduce
downstream signals through Gs/cAMP, Gq/phospholipase C
(PLC), and G13/Rho pathways [15,16,17,20]. cAMP is a
ubiquitous second messenger that controls a wide range of cellular
processes mainly through the downstream effector protein kinase
A (PKA). More recently, Epac (exchange protein directly activated
by cAMP) has been identified as a new effector of cAMP and is
involved in many important cellular processes including cell
adhesion [32,33]. The cAMP/Epac/Rap1 signaling pathway has
been reported to regulate a number of PKA-independent
processes, such as b2-adrenergic receptor-mediated ovarian
carcinoma cell adhesion to fibronectin [34], monocyte adhesion
and chemotaxis [35], and adenosine receptor-stimulated activation
of ERK1/2 in HUVEC cells [36].
Here we have identified a novel function of GPR4 in response
to acidosis. Activation of GPR4 by acidic pH increases endothelial
cell adhesion with leukocytes and this biological effect is mediated
through the cAMP/Epac pathway. Acidosis/GPR4 signaling also
up-regulates the expression of several adhesion molecules in
endothelial cells. These findings suggest that the acidosis/GPR4
signaling may represent a new pathway in vascular inflammation
responding to acidic microenvironments in many pathological
conditions.
Materials and Methods
Reagents and chemicals
29,59-dideoxyadenosine (DDA), SQ 22536, 8-bromoadenosine
39,59-cyclic monophosphate (8-Br-cAMP), 8-(p-chlorophenylthio)-
29-O-methyladenosine-39,59-cyclic monophosphate (8-CPT-2Me-
cAMP), H-89, and pertussis toxin (PTX) were purchased from
Calbiochem/EMD4Biosciences (La Jolla, CA). 3-isobutyl-1-meth-
ylxanthine (IBMX), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid (HEPES), N-(2-hydroxyethyl)-piperazine-N9-3-propanesulfo-
nic acid (EPPS), 2-(4-morpholino)-ethanesulfonic acid (MES), and
protease inhibitor cocktail were from Sigma-Aldrich (St Louis,
MO) and Fisher Scientific (Fair Lawn, NJ). Anti-c-myc mouse
monoclonal antibody (clone 9E10) was purchased from Roche
Diagnostics (Indianapolis, IN). E-selectin (clone BBIG-E4),
VCAM-1 (clone BBIG-V1), inter-cellular adhesion molecule-1
(ICAM-1) (clone BBIG-I1) and P-selectin (clone 9E1) monoclonal
antibodies were from R&D Systems (Minneapolis, MN).
Plasmid constructs
The open reading frame of human GPR4 (GenBank accession
number NM 005282) was amplified from human cDNAs by
polymerase chain reaction (PCR) with the high-fidelity pfu-turbo
DNA polymerase (Stratagene, La Jolla, CA). The PCR primer
pair was: sense strand 59- ATAAGAATGCGGCCGCACCA-
TGGGCAACCACACGTG -39 and antisense strand 59- ATAA-
GAATGCGGCCGCTCATTGTGCTGGCGGCAGCAT -39. A
NotI site was introduced at each end of the PCR fragment for
molecular cloning and the Kozak consensus sequence was added
before the translation start codon ATG for efficient translation.
The amplified PCR fragment was digested with NotI and cloned
into the retroviral expression vector MSCV-IRES-GFP as
previously described [37,38]. The coding region of the resultant
construct, designated as MSCV-huGPR4-IRES-GFP, was verified
by DNA sequencing from both strands.
To generate the dominant-negative construct of Epac1 [39], a
cDNA fragment encoding the N-terminal 420 amino acids of
Epac1 was amplified by PCR from the HUVEC cDNA. The
nucleotide sequence of the myc tag was designed to be added to
the 59 of the Epac1 sequence. A NotI site at the 59 end and an
EcoRI site at the 39 end were designed for cloning into expression
vectors. The PCR primers for amplifying the dominant-negative
Epac1 fragment were: sense strand 59- AGAGGGCGGCCG-
CACCATGGAGCAAAAGCTCATTTCTGAAGAGGACTTG-
GTGTTGAGAAGGATGCACCGGCCC -39 and antisense
strand 59-GAGAGGAATTCCTACCTCTTGTTGCAGACGT-
AGGTGCT-39. The amplified Epac fragment was digested with
NotI and EcoRI and subcloned into the pQCXIP vector
(Clontech, CA). The construct was sequenced to verify the
accuracy of the coding sequence. The dominant-negative Epac
construct was designated as pQCXIP-N-Epac.
Site-directed mutagenesis
The DRY motif of GPCRs is important for G protein coupling
and signaling [40]. A pair of primers was designed to generate an
arginine to alanine mutation at the residue 115 (namely R115A) of
the DRY motif of GPR4. The sequences of the primer pair were:
sense strand 59- TGCATCTCGGTGGACGCCTACCTGGCT-
GTG -39 and antisense strand 59- CACAGCCAGGTAGG-
CGTCCACCGAGATGCA -39. The MSCV-huGPR4-IRES-
GFP plasmid construct was used as the template and the R115A
mutation was generated using the QuikChange site-directed
mutagenesis kit (Stratagene, Inc., CA). The mutagenesis procedure
was performed according to the manufacturer’s instruction. The
R115A mutation was confirmed by DNA sequencing and no other
mutations were detected.
RNAi knockdown
The microRNA-based short-hairpin RNA interference
(miRNA) vector system (Invitrogen, Carlsbad, CA) was used for
the RNAi knockdown of human GPR4 gene expression in
HUVEC cells. Perfectly matched miRNA molecules mainly cause
the degradation of target mRNAs. Several sets of miRNAs against
human GPR4 were designed according to the manufacturer’s
instructions (www.invitrogen.com/rnai). The core nucleotide
sequences of two effective human GPR4 miRNA molecules were:
miRNA #1: (sense) 59-ATCCCTCTACATCTTTGTCAT-39
and (antisense) 59-ATGACAAAGATGTAGAGGGAT-39, and
miRNA #2: (sense) 59-CAAGAGGAACAGCACAGCCAA-39
and (antisense) 59-TTGGCTGTGCTGTTCCTCTTG-39. A
negative control miRNA that does not have sequence homology
with any known genes was provided by Invitrogen. The core
sequence of the negative control miRNA was: (sense) 59-GT-
CTCCACGCGCAGTACATTT-39 and (antisense) 59-AAATG-
TACTGCGCGTGGAGAC-39. The pre-miRNA oligos were
cloned into the pcDNA 6.2-GW/RFP-miR vector and transferred
to the lentiviral vector FCW attR1-attR2 using the BP/LR
recombination reaction system (Invitrogen) as previously described
[41]. All miRNA constructs were verified by DNA sequencing.
The miRNA lentiviral vector was co-transfected with the
packaging vectors pRSV-Rev, pCMV-VSV-G, and pMDL into
HEK 293T cells (ATCC, Manassas, VA). Viral particles were
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produced and used to transduce HUVEC cells to express the
miRNA molecules.
Cell culture and retroviral transduction
All cells were cultured in a humidified tissue culture incubator
with 5% CO2 and 95% air at 37uC. Primary HUVECs were
purchased from Lonza (Walkersville, MD, previously known as
Clonetics) and grown in endothelial cell growth medium 2 (EGM-
2) (Lonza) as previously described [15]. U937 monocytic cell line
was originally from American Type Culture Collection (ATCC,
Manassas, VA). U937 cells were maintained in Dulbecco’s
modified Eagle’s medium (DMEM) (Invitrogen) supplemented
with 10% fetal bovine serum (FBS) (Invitrogen or HyClone,
Logan, UT). To prepare retroviral particles for cell transduction,
the MSCV or pQCXIP retroviral construct was co-transfected
with the amphotropic packaging vector pCL-10A1 (Imgenex, CA)
into HEK 293T cells (ATCC, Manassas, VA) to make replication-
deficient viral particles, which were used to transduce HUVEC
cells to express target genes. HUVECs stably expressing the
MSCV-IRES-GFP, MSCV-huGPR4-IRES-GFP, or MSCV-
huGPR4 R115A-IRES-GFP construct were isolated by fluores-
cence-activated cell sorting (FACS) based on green fluorescent
protein (GFP) signals. HUVECs transduced with the pQCXIP or
pQCXIP-N-Epac construct were selected with 2 mg/ml puromy-
cin to enrich cells with the expression vector.
Cell adhesion assay
The U937-HUVEC cell adhesion assay was performed as
previously described [42,43] with minor modifications. This
approach examines the adhesion of U937 monocytic cells to a
HUVEC monolayer under a static condition with no flow.
Primary HUVECs from passage 3 to 7 were used for the cell
adhesion assay. For isocapnic pH medium preparation, the pH
buffering of cell culture media were carried out as previously
described [15,19]. Briefly, EGM-2 media were buffered with
7.5 mM HEPES, 7.5 mM EPPS and 7.5 mM MES (named as
HEM), and the pH was adjusted using NaOH or HCl and
measured with a pH meter (Fisher). To prepare hypercapnic pH
media, EGM-2 media were added to cell culture plates and
incubated in humidified tissue culture incubators filled with
ambient air, 5% CO2 or 20% CO2, respectively. The pH of the
EGM-2 media pre-treated under these conditions was measured to
be around 8.4, 7.4 and 6.4, respectively. HUVECs stably
expressing the MSCV-IRES-GFP vector, MSCV-huGPR4-
IRES-GFP, MSCV-huGPR4 R115A-IRES-GFP, GPR4 miRNAs
or control miRNA were cultured in a 24-well plate with EGM-2
media to form a confluent monolayer. For isocapnic pH
treatment, HUVECs were incubated in the EGM-2/HEM media
at various pHs for 5 h to 15 h (overnight) in a regular incubator
with 5% CO2. For hypercapnic pH treatment, HUVECs were
treated with CO2-buffered EGM-2 pH media for 5 h in incubators
with ambient air, 5% CO2 or 20% CO2, respectively. After the
pH treatment, HUVEC cells were washed once with DMEM at
pH 7.4. To exclude the effects of acidosis on U937 monocytic
cells, the step of U937 cell attachment to HUVEC cells was
carried out at pH 7.4. U937 cells were resuspended in DMEM/
HEM media with 10% FBS at pH 7.4, added at a density of
66104 cells/well in 1 ml of medium to a 24-well plate with
HUVEC monolayer, and incubated for 1 h to allow cell
attachment. Wells of the plate were gently washed with warm
DMEM medium containing 10% FBS for at least 5 times to
remove non-adherent U937 cells. Attached U937 cells from three
random fields (excluding the edge of the wells which tended to
have non-specific cell binding) were counted under an inverted
microscope with a 106 objective (total 1006magnification) and
the number of U937 cells per field was used as a functional
readout to measure the adhesion capacity of HUVECs. To
investigate the signaling pathways and adhesion molecules
involved in acidosis/GPR4-induced cell adhesion, HUVECs were
treated with various agents and blocking antibodies. The details of
treatment conditions were described in the figure legends and/or
in the results section.
cAMP assay
The production of cAMP in HUVECs was measured using the
Amersham cAMP Biotrak Enzymeimmunoassay (EIA) kit from
GE Healthcare (Piscataway, NJ) following the manufacturer’s
instruction. Briefly, 2.56104 HUVEC cells/well were cultured in a
96-well plate and treated with 200 ml/well of EGM-2/HEM
media or with CO2-buffered EGM-2 pH media at various pHs in
the presence of 0.5 mM IBMX for 15 to 20 min. After the media
were removed, 200 ml/well of lysis reagent 1B was immediately
added to break cell membranes and release intracellular cAMP.
100 ml of cell lysate was transferred to a well of a donkey anti-
rabbit Ig-coated plate. 100 ml of rabbit anti-cAMP antiserum was
added and incubated for 2 h on ice, followed by the addition of
50 ml of cAMP-peroxidase conjugate and incubation for 1 h on
ice. After all wells were washed with 400 ml of wash buffer four
times, 150 ml of enzyme substrate was added into each well and
incubated for 30 min at room temperature. The reaction was
stopped by adding 100 ml/well of 1 M sulphuric acid, and the
optical density was determined at 450 nm using a microplate
reader (Molecular Devices, CA). The total intracellular cAMP was
calculated according to the cAMP standard measured in parallel.
Real-time RT-PCR (reverse transcriptase-polymerase
chain reaction)
Human GPR4 gene expression was measured in HUVECs that
were transduced with the control vector, GPR4 or miRNAs and
grown in regular EGM-2 medium. The gene expression of
endothelial adhesion molecules was assessed in HUVECs that were
transduced with the control vector, GPR4 or GPR4 R115A mutant
and treated with EGM-2/HEM media at pH 8.4, 7.4, and 6.4 or
CO2-buffered EGM-2 pH media for 5 h. Total RNAs were
extracted from HUVECs using the RNeasy Plus kit (QIAGEN,
MD), and were reverse transcribed using the SuperScript II reverse
transcriptase (Invitrogen, CA). Real-time PCR reagents were
purchased from Applied Biosystems Inc (ABI, Foster City, CA).
Primers specific for the adhesion molecules were the TaqMan Gene
Expression Assays from ABI: VCAM-1, Hs01003372_ml; E-
selectin, Hs00174057_ml; ICAM-1, Hs99999152_ml; P-selectin,
Hs00174583_m1. The sequences of human GPR4 primers were:
(sense) 59-TTCGAGGAGCGCGTCTTT-39, (antisense) 59-
GGTCCGCCACACAGTTGA-39, and probe FAM-59- CTGCA-
TACCACAGCTCACTGGCTTTCAC -39-TAMRA as previous-
ly described [44]. Human glyceraldehydes-3-phophate dehydroge-
nase (GAPDH) TaqMan Gene Expression Assay (ABI, Cat. #
4333764T) was used as the internal control. Real-time PCR was
performed in duplicate with a program of 50uC for 2 min, 95uC for
10 min followed by 40 cycles of 95uC for 15 s and 60uC for 1 min,
and the data was acquired and analyzed using the ABI 7300-HT
real-time PCR thermocycler.
Western blot analysis
HUVECs transduced with the myc-tagged N-Epac construct or
the control pQCXIP vector were lysed in ice-cold RIPA lysis
buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% Triton X-
Acidosis/GPR4 and Endothelial Cell Adhesion
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100, 0.25% Na-deoxycholate, 1 mM EDTA, 1 mM phenyl-
methylsulfonyl fluoride, 1 mM Na3VO4, 1 mM NaF, 5% protease
cocktail inhibitor from Sigma) for 15 min at 4uC. The cell lysates
were clarified by centrifugation at 14,0006 g for 15 min at 4uC.
Protein concentration of the supernatant was determined by the
Bradford protein assay (Bio-Rad, Hercules, CA). The expression of
myc-tagged N-Epac was analyzed by Western blotting with the
mouse monoclonal anti-c-myc antibody (Roche), followed by the
incubation with the horseradish peroxidase (HRP)-conjugated
goat anti-mouse IgG (H+L) secondary antibody (Bio-Rad).
Chemiluminescence signals were detected using the Amersham
ECL Advance Western blotting detection kit (GE Healthcare).
Immunofluorescence
The immunostaining was performed as previously described
with minor modifications [15,45]. All staining steps were carried
Figure 1. Acidosis/GPR4-induced adhesion of HUVEC cells. (A) HUVECs stably expressing the MSCV-huGPR4-IRES-GFP construct (GPR4) or the
MSCV-IRES-GFP control vector (Vector) were grown as a flat monolayer and treated with EGM-2/HEM media at varying pH for either 5 h or 15 h
(overnight) which showed similar results. Then, 66104 cells/well of U937 monocytic cells were added to adhere with HUVECs for 1 h at pH 7.4, and
the static cell adhesion assay was performed as described in the ‘‘Materials and Methods’’. After the adhesion assay, the attached U937 cells were
readily detected as small, round and reflectile cells under an inverted microscope with a 106 objective. Arrows indicate attached U937 cells. (B)
HUVECs stably overexpressing GPR4 or the control vector were treated with different pHs as indicated. The cell adhesion assay was then performed.
*, P,0.05; ***, P,0.001; compared with the pH 8.2 group. (C) HUVECs were transduced with various genetic constructs as indicated. Total RNA was
isolated and mRNA levels of GPR4 were determined by real-time RT-PCR. Values were normalized to the housekeeping gene GAPDH. The expression
level of GPR4 in HUVECs with the control vector was set as 1. (D) HUVECs stably overexpressing the mouse GPR4-GFP fusion gene were treated with
different pHs as indicated, and then the cell adhesion assay was performed. Error bars are the mean 6 SEM. *, P,0.05, compared with pH 8.4. (E)
HUVECs were transduced with two GPR4 miRNAs or control miRNA, followed by pH treatment, and then the cell adhesion assay was performed.
*, P,0.05; **, P,0.01; compared with the control miRNA group at pH 6.4. (F) HUVEC/GPR4 cells were treated with different pHs for various lengths of
time as indicated, and then the cell adhesion assay was performed. **, P,0.01; ***, P,0.001; compared with the 1 h group at pH 6.4. The results are
depicted as the mean 6 SEM and representative of more than two independent experiments.
doi:10.1371/journal.pone.0027586.g001
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out at room temperature. Briefly, HUVEC/Vector and HUVEC/
GPR4 cells were seeded in 8-well chamber slides, and grown
overnight to allow cells to attach. Cells were then treated with
EGM-2/HEM media at pH 8.4, 7.4, and 6.4 for 5 h, or with
EGM-2 medium containing 10 nM thrombin for 20 min (for P-
selectin only). After the treatment, cells were washed once with
PBS and fixed with 4% paraformaldehyde in PBS for 15 min.
Cells were then washed three times with PBS, permeabilized with
PBST (PBS with 0.1% Tween 20) for 4 min and incubated with
the blocking solution consisting of 5% normal goat serum in PBST
for 30 min. For P-selectin staining, cells were fixed with 100%
methanol at 220uC for 10 min, without the need for additional
cell permeabilization. Afterwards, mouse monoclonal primary
antibodies diluted in the blocking solution, including E-selectin
antibody, VCAM-1 antibody, ICAM-1 antibody, or P-selectin
antibody (R&D Systems), were applied to the cells at the
concentration of 10 mg/ml and incubated for 1 h. After several
washes with PBST, cells were incubated with Rhodamine Red-
conjugated goat anti-mouse IgG secondary antibody (1:200)
(Invitrogen, R6393) for 1 h. Thereafter, unbound antibodies were
removed by several washes with PBS, and cells were mounted in
the anti-fade mounting medium (Vector Laboratories) and
examined under a fluorescence microscope (Nikon) connected
with a digital camera (Zeiss).
Statistical analysis
Data were analyzed using the GraphPad Prism 5 software
(GraphPad Software, Inc., CA) and depicted as mean 6 SEM.
P,0.05 was considered statistically significant.
Results
Activation of GPR4 by isocapnic acidosis increases HUVEC
cell adhesion
Primary HUVECs, which have endogenous GPR4 expression,
were used as a model system to study the effects of acidosis/
GPR4 signaling on endothelial cell adhesion. HUVECs were
stably transduced with the MSCV-IRES-GFP retroviral control
vector (designated as HUVEC/Vector cells) or the MSCV-
huGPR4-IRES-GFP construct (designated as HUVEC/GPR4
cells). To examine the adhesiveness of HUVEC cells and to
model the interaction between endothelium and blood cells, we
utilized the static HUVEC-U937 monocyte attachment assay as
a functional readout [42,43]. After non-adherent cells were
removed by several washes, the U937 cells attached to the flat
HUVEC monolayer could be readily detected as small, round
and reflectile cells under an inverted microscope (Fig. 1A). For
pH treatment, EGM-2 media were buffered with the chemicals
HEPES, EPPS and MES (collectively as HEM) and the pH was
adjusted with HCl or NaOH to generate isocapnic acidosis or
alkalosis. When HUVEC/Vector cells were treated with pH 8.2,
7.8 and 7.4 (6.3 nM, 15.8 nM, and 40 nM H+, respectively), the
cells exhibited a low capacity to adhere U937 monocytes. The
treatment of pH 7.0 and 6.6 (100 nM and 251 nM H+,
respectively) increased HUVEC/Vector cell adhesion by 2- to
4-fold (Fig. 1B). With the overexpression of human GPR4 in
HUVEC/GPR4 cells, acidosis significantly augmented the
adhesiveness of HUVEC cells by 5- to 10-fold (Fig. 1B). As
measured by real-time RT-PCR, GPR4 was overexpressed
about 12-fold in HUVEC/GPR4 cells when compared to
HUVEC/Vector cells (Fig. 1C). Similarly, in HUVEC cells
overexpressing the mouse GPR4-GFP fusion gene [15,19], a
significant increase of HUVEC adhesiveness was also observed
upon acidic pH treatment (Fig. 1D). U937 cells cultured in
RPMI medium showed similar results as that from the cells
cultured in DMEM medium (Fig. S1A). In addition to U937
monocytes, the adhesion of HUVECs with another type of
leukocytes, the HL-60 promyelocytic cells (neutrophils), under
the static condition was also increased when HUVECs were
stimulated by acidosis/GPR4 (Fig. S1B). These results suggest
that activation of GPR4 by acidosis induces an adhesive
phenotype of HUVECs.
To further investigate the role of GPR4 in endothelial cell
adhesion induced by isocapnic acidosis, microRNAs-based
short-hairpin RNA interference (miRNAs) was used to knock-
down the endogenous GPR4 gene expression in HUVECs. We
tested several miRNAs targeting different regions of GPR4
mRNA and identified two independent miRNAs that efficiently
down-regulated GPR4 expression by more than 80% in
HUVECs as measured by real-time RT-PCR (Fig. 1C). A
negative control miRNA without sequence homology did not
inhibit GPR4 expression. In the U937-HUVEC cell adhesion
assay, acidosis increased the adhesiveness of HUVECs trans-
duced with the negative control miRNA, but not HUVECs
Figure 2. G protein signaling is indispensible for acidosis/GPR4-induced HUVEC adhesion. (A) HUVECs were transduced with GPR4 or the
GPR4 R115A mutant expression vector. The intracellular cAMP level in HUVECs was determined by the cAMP assay as described under ‘‘Materials and
Methods’’. The total intracellular cAMP was calculated according to the cAMP standard measured in parallel. *, P,0.05; ns, not significant (P.0.05). (B)
HUVEC cells as described in (A) were treated with indicated pHs and the cell adhesion assay was performed as described under ‘‘Materials and
Methods’’. ***, P,0.001. The results are representative of two independent experiments. Error bars are the mean 6 SEM.
doi:10.1371/journal.pone.0027586.g002
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transduced with those two miRNAs that inhibited the endog-
enous GPR4 expression (Fig. 1E). These results suggest that the
expression of GPR4 is required for acidosis-stimulated HUEVC
adhesion.
We next examined the time course of acidosis/GPR4-
induced endothelial cell adhesion. HUVEC/GPR4 cells were
treated with EGM-2/HEM media at pH 6.4, 7.4 and 8.4 for 1,
3, 5, 24, and 48 hours and then U937 monocytes were added
for the adhesion assay. As shown in Figure 1F, by 1 hour we
did not observe an increase of HUVEC cell adhesion. By
3 hours, pH 6.4 (400 nM H+), compared to pH 8.4 (4 nM H+)
and pH 7.4 (40 nM H+), significantly augmented the adhe-
siveness of HUVECs. By 5 to 24 hours, we observed the peak
induction of HUVEC adhesion by acidic pH. By 48 hours, the
induction was decreased when compared to that at 5 and
24 hours. The results suggest that the acidosis/GPR4-induced
HUVEC adhesion occurs within 3 hours after the acidic pH
stimulation.
Figure 3. Involvement of cAMP in acidosis/GPR4-induced HUVEC adhesion. (A) The intracellular cAMP level in pH-treated HUVEC/Vector
cells was determined by the cAMP assay as described in the ‘‘Materials and Methods’’. *, P,0.05; compared with pH 8.4. (B) HUVECs stably
overexpressing GPR4 or the control vector were pretreated with vehicle or 100 mM 29,59-dideoxyadenosine (DDA) for 1 h, followed by the treatment
with indicated pH media containing vehicle or 100 mM DDA for 5 h, and the cell adhesion assay was performed as described in the ‘‘Materials and
Methods’’. *, P,0.05; ***, P,0.001. (C) HUVECs stably overexpressing GPR4 or the control vector were pretreated with vehicle or SQ 22536 (1 mM) for
1 h, followed by the treatment with indicated pH media containing vehicle or 1 mM SQ 22536 for 5 h, and then the cell adhesion assay was
performed. *, P,0.05; **, P,0.01. (D) HUVECs stably overexpressing GPR4 or the control vector were treated with indicated pH media containing
vehicle or 500 mM 8-bromo-cAMP for 15 h (overnight), and then the cell adhesion assay was performed. (E) HUVEC/GPR4 cells were treated with
indicated pH media containing vehicle or 100 ng/ml PTX for 15 h, and then the cell adhesion assay was performed. All the above results are
representative of at least two independent experiments. Error bars are the mean 6 SEM.
doi:10.1371/journal.pone.0027586.g003
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Gs/cAMP signaling is important for acidosis/GPR4-
induced HUVEC cell adhesion
GPCRs are cell surface receptors that transduce signals mainly
through G protein coupling [46,47,48], but G protein-indepen-
dent pathways have also been reported [49]. Some GPCRs,
particularly those with a long amino-terminal extracellular
domain, can directly function as adhesion molecules to increase
cell adhesion [50]. GPR4 does not have a long amino-terminal
extracellular domain and thus is unlikely to serve as an adhesion
molecule per se. Furthermore, we observed that the mRNA level
of GPR4 was actually decreased by ,50% in HUVEC/Vector
cells upon acidosis treatment for 5 h (Fig. S2). This may represent
a regulatory mechanism to down-regulate GPR4 signaling after its
activation by acidosis, and the results also indicate that GPR4 itself
may not directly act as an adhesion molecule to increase HUVEC
adhesiveness. To elucidate GPR4 downstream pathways and to
further rule out the possibility that GPR4 mediates cell adhesion
by functioning as an adhesion molecule, we generated a GPR4
mutant with the arginine 115 to alanine (R115A) mutation in the
DRY motif, which is located at the second intracellular loop and
important for G protein signaling [38,40]. The GPR4 R115A
mutant was transduced into HUVEC cells (designated as
HUVEC/GPR4 R115A cells) and the expression of the GPR4
R115A mutant was at the comparable level as that of GPR4 in
HUVEC/GPR4 cells (data not shown). To examine the G protein
signaling of the GPR4 R115A mutant, acidosis/GPR4-induced
cAMP production was measured. Acidic pH stimulated the
production of cAMP by about 7-fold in HUVEC/GPR4 cells
but not in the HUVEC/GPR4 R115A cells (Fig. 2A), suggesting
that the R115A mutant is defective in G protein signaling. Upon
the treatment of pH 6.4, HUVECs overexpressing the wild-type
GPR4 showed a ,10-fold increase of adhesion with U937 cells.
However, overexpression of the GPR4 R115A mutant did not
augment HUVEC cell adhesion at acidic pH (Fig. 2B). These
results indicate that G protein signaling is indispensable for
acidosis/GPR4-mediated endothelial cell adhesion.
Since GPR4 was co-expressed with a bicistronic GFP marker,
we examined whether the adhesiveness of HUVEC cells is linearly
correlated with the intensity of GFP signal, an indicator of GPR4
expression. Overall, the GFP signal was heterogeneous and
relatively low in the transduced HUVECs (Fig. S3). Some
HUVEC cells with strong GFP signals did not always showed
strong adhesion with U937 cells and, on the other hand, some
HUVEC cells with low to medium GFP signals exhibited high
Figure 4. Epac is important for HUVEC adhesion induced by acidosis/GPR4. (A) HUVEC/GPR4 cells were pretreated with vehicle or H-89
(10 mM) for 1 h. Cells were then treated with indicated pH media containing vehicle or 10 mM H-89 for 5 to 15 h (overnight), and the cell adhesion
assay was performed as described under ‘‘Materials and Methods’’. ns, not significant (P.0.05). (B) HUVEC/Vector or HUVEC/GPR4 cells were stably
transduced with the myc-tagged Epac dominant-negative construct N-Epac or the control vector pQCXIP. Total proteins were extracted from HUVEC
cells and subject to Western blot analysis for myc-N-Epac with anti-myc antibodies. GAPDH was used as a loading control. (C) HUVEC/Vector or
HUVEC/GPR4 cells were stably transduced with the dominant-negative N-Epac or the control vector pQCXIP. Cells were treated with indicated pH
media for 5 or 15 h and then the cell adhesion assay was performed. **, P,0.01; ***, P,0.001. (D) HUVEC/GPR4 cells were treated with indicated pH
media containing vehicle or 100 mM 8-CPT-2Me-cAMP for 15 h, and then the cell adhesion assay was performed. All the above results are
representative of two or more independent experiments. Error bars are the mean 6 SEM.
doi:10.1371/journal.pone.0027586.g004
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adhesiveness (Fig. S3). The results suggest that acidosis/GPR4-
induced HUVEC cell adhesion may not be linearly proportional
to the overexpression of GPR4 per se but be related to
downstream events triggered by GPR4 activation.
To further delineate downstream pathways, we examined
whether the Gs/adenylate cyclase/cAMP pathway is important for
acidosis/GPR4-induced endothelial cell adhesion. In addition to
acidosis-induced cAMP production (,7-fold) in HUVEC/GPR4
cells (Fig. 2A), a ,1.5-fold increase of cAMP upon acidic pH
stimulation was detected in HUVEC/Vector cells (Fig. 3A).
Furthermore, inhibition of adenylate cyclase by 29,59-dideoxyade-
nosine (DDA) attenuated acidosis/GPR4-induced HUVEC adhe-
sion (Fig. 3B). A similar extent of decrease in HUVEC adhesiveness
was observed when cells were treated with another adenylate cyclase
inhibitor SQ 22536 (Fig. 3C). Consistently, direct introduction of a
cAMP analog, 8-bromo-cAMP, increased the adhesion of HUVECs
at all tested pHs, recapitulating the effects of GPR4 activation
(Fig. 3D). In line with this observation, treatment of HUVEC/GPR4
cells with pertussis toxin (PTX), which blocks the cAMP inhibitory G
protein Gi, increased the adhesion of HUVECs (Fig. 3E). These
results indicate that the Gs/cAMP pathway plays an important role
in regulating acidosis/GPR4-mediated HUVEC adhesion.
The cAMP effector, Epac, is involved in acidosis/GPR4-
induced HUVEC cell adhesion
Increase of intracellular cAMP can activate several down-
stream effectors including protein kinase A (PKA) and Epac
[51]. To determine which effector(s) are involved in acidosis/
GPR4-induced HUVEC adhesion, we first examined the role of
the best characterized cAMP target, PKA, in this process.
Treating HUVEC/GPR4 cells with the PKA inhibitor H-89 did
not affect cell adhesion induced by acidosis (Fig. 4A), suggesting
that PKA is not important for this process. To verify that H-89
effectively inhibited the activity of PKA, we examined the
phosphorylation status of the PKA substrate CREB (cAMP
response element-binding) by Western blotting and showed that
H-89 effectively blunted CREB phosphorylation induced by 8-
bromo-cAMP in HUVECs (data not shown). Next, to elucidate
the role of Epac in acidosis/GPR4-mediated HUVEC adhesion,
a dominant-negative Epac mutant N-Epac or the pQCXIP
control vector was expressed in HUVEC/Vector and HUVEC/
GPR4 cells. The N-Epac dominant-negative mutant lacks the
kinase domain and blocks the activity of Epac by competitively
binding with the substrates [39]. By Western blotting with a myc
antibody, the exogenous expression of myc-N-Epac was
confirmed in HUVEC/Vector and HUVEC/GPR4 cells
(Fig. 4B). In the HUVEC-U937 adhesion assay, the expression
of the N-Epac mutant inhibited acidosis/GPR4-induced HU-
VEC cell adhesion (Fig. 4C). On the other hand, when HUVEC
cells were directly treated with the Epac specific activator 8-
CPT-2Me-cAMP [52], cell adhesion was enhanced at all pHs
tested (Fig. 4D). These results suggest that Epac, but not PKA, is
the downstream cAMP effector that mediates acidosis/GPR4-
induced HUVEC adhesion.
Figure 5. Real-time RT-PCR of adhesion molecules E-selectin, VCAM-1, and ICAM-1. HUVECs transduced with the control vector, GPR4 or
GPR4 R115A mutant were treated with EGM-2/HEM media at pH 8.4, 7.4, or 6.4 for 5 h. Total RNAs were isolated and reverse transcribed. Real-time
RT-PCR quantification of mRNA levels of E-selectin (A), VCAM-1 (B), and ICAM-1 (C) was performed in duplicate. Values were normalized to the
housekeeping gene GAPDH. The expression level of the target gene in HUVEC/Vector cells at pH 8.4 was set as 1. The results are representative of at
least two independent experiments. Error bars are the mean 6 SEM.
doi:10.1371/journal.pone.0027586.g005
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Activation of GPR4 by acidosis increases the expression
of endothelial adhesion molecules E-selectin, VCAM-1,
and ICAM-1
During leukocyte extravasation, the early steps like leukocyte
tethering, rolling and firm adhesion are associated with elevated
expression of endothelial cell adhesion molecules, such as E-
selectin, vascular cell adhesion molecule-1 (VCAM-1), and
intercellular adhesion molecule-1 (ICAM-1), three extensively
characterized endothelial adhesion molecules [53,54]. To inves-
tigate the gene expression levels of these adhesion molecules, we
used real-time RT-PCR to examine their mRNA levels in pH-
treated HUVEC cells transduced with different GPR4 constructs.
Levels of VCAM-1 and E-selectin mRNAs were increased by
about 7-fold upon acidosis treatment in HUVEC/Vector cells
expressing the endogenous level of GPR4. Moreover, overexpres-
sion of GPR4 in synergy with acidosis further enhanced the gene
expression of VCAM-1 and E-selectin substantially (Figs. 5A and
B). Acidosis/GPR4 stimulated the expression of ICAM-1,
however, to a lesser extent as there was both a minor increase in
HUVEC/Vector cells and an increase of 10-fold in HUVEC/
Figure 6. Immunofluorescence staining of E-selectin, VCAM-1 and ICAM-1 in HUVEC cells. After treated with EGM-2/HEM media at
pH 8.4, 7.4, or 6.4 for 5 h, HUVEC/Vector and HUVEC/GPR4 cells were fixed with 4% paraformaldehyde, incubated with E-selectin, VCAM-1 or ICAM-1
primary antibody, Rhodamine Red-conjugated secondary antibody, and then detected under a fluorescence microscope (106 objective). For an
accurate comparison of fluorescence signals, each group of images (e.g. E-selectin/Vectors cells, pH 8.4, pH 7.4, and pH 6.4) was taken with the same
exposure time. The results are representative of three independent experiments.
doi:10.1371/journal.pone.0027586.g006
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GPR4 cells (Fig. 5C). In contrast, overexpression of the GPR4
R115A mutant failed to further augment the mRNA levels of these
adhesion molecules upon acidosis stimulation in HUVEC cells
(Figs. 5A, B and C). These results are in accordance with the U937
monocyte adhesion assay results (Figs. 1B and 2B).
Immunofluorescence staining was performed to assess the
expression of E-selectin, VCAM-1, and ICAM-1 at the protein
level. When HUVEC/Vector and HUVEC/GPR4 cells were
treated with pH 8.4 and pH 7.4, the expression of E-selectin,
VCAM-1, and ICAM-1 was at the basal level. Acidic pH 6.4
treatment stimulated the expression of E-selectin and ICAM-1 in
HUVEC/Vector cells and the expression was further increased in
HUVEC/GPR4 cells (Fig. 6). While VCAM-1 was barely
detectable by this antibody in HUVEC/Vector cells, its expression
was clearly up-regulated by pH 6.4 in HUVEC/GPR4 cells
(Fig. 6). We also examined whether acidosis/GPR4 could induce
the expression or membrane translocation of P-selectin, another
adhesion molecule in endothelial cells [55,56,57]. The real-time
RT-PCR result did not show any significant up-regulation of P-
selectin mRNA in HUVECs induced by acidosis/GPR4 (Fig.
S4A). Moreover, we could not detect cell membrane translocation
of P-selectin protein from the Weibel-Palade body by the acidosis
treatment for 5 h (Fig. S4B) or 20 min (data not shown). In
comparison, the thrombin treatment for 20 min as a positive
control induced the translocation of P-selectin to cell membrane
(Fig. S4B).
Collectively, the results suggest that activation of GPR4 by
acidosis in HUVEC cells increases the expression of multiple
endothelial adhesion molecules including E-selectin, VCAM-1 and
ICAM-1, which may interact with their receptors on U937 cells to
mediate the adhesion.
Blockade of endothelial E-selectin, VCAM-1, and ICAM-1
on HUVECs reduces acidosis/GPR4-mediated cell
adhesion
Monoclonal blocking antibodies were used to examine whether
E-selectin, VCAM-1, and ICAM-1 are functionally involved in
acidosis/GPR4-induced HUVEC adhesion. After the treatment
with different pHs for 5 h, HUVEC/GPR4 cells were incubated
with E-selectin, VCAM-1, ICAM-1 blocking antibodies or the
mouse IgG1 control and the static cell adhesion assay was
performed. Compared to the IgG1 control, each of the three
blocking antibodies significantly decreased the adhesion of
HUVECs with U937 monocytes (Fig. 7). It was also noted that
the ICAM-1 antibody caused an increase of basal adhesion for
unknown reasons. The blocking antibody results suggest that
multiple adhesion molecules, including E-selectin, VCAM-1 and
ICAM-1, are functionally important for acidosis/GPR4-induced
HUVEC adhesion with U937 monocytes.
Hypercapnic acidosis can also activate GPR4 to increase
the adhesion molecule expression and the adhesiveness
of HUVECs
In all the results described above, HUVECs were treated with
isocapnic acidosis in which EGM-2 media were buffered with
HEPES, EPPS and MES and the acidic pH was obtained by
adding HCl. Hypercapnic acidosis, caused by an increase in
carbon dioxide in tissues, blood or body fluid, is another type of
acidosis that is associated with many pathological conditions
[9,11]. To investigate the effects of hypercapnic acidosis on GPR4
signaling, HUVEC/Vector and HUVEC/GPR4 cells were
treated with EGM-2 culture media under ambient air (,0.04%
CO2), 5% CO2 and 20% CO2. The pHs of the EGM-2 media
under these levels of CO2 were around 8.4, 7.4 and 6.4,
respectively. As measured by real-time RT-PCR, the hypercapnic
acidosis treatment (20% CO2), in comparison to 5% CO2 and
ambient air, increased the expression of E-selectin, VCAM-1 and
ICAM-1 mRNA by several fold in HUVEC/Vector cells, and the
expression was further substantially induced in HUVEC/GPR4
cells but not HUVEC/GPR4 R115A mutant cells (Figs. 8A, B and
C). Moreover, the hypercapnic acidosis (20% CO2) treatment
stimulated the production of cAMP in HUVEC/Vector cells, with
further increase in HUVEC/GPR4 cells (Fig. 8D). Concordantly,
the hypercapnic treatment augmented the adhesiveness of
HUVEC/Vector cells, and this effect was particularly robust in
HUVEC/GPR4 cells (Fig. 8E). These results suggest that, similar
as isocapnic acidosis, hypercapnic acidosis can also activate GPR4
to induce the expression of the endothelial adhesion molecules,
stimulate cAMP production, and increase HUVEC adhesiveness.
Discussion
Acidosis has been shown to regulate vascular tone, blood vessel
growth, and the function of smooth muscle and endothelial cells
[12,58,59]. At the molecular level, ATP-sensitive potassium
channels, activated by intracellular acidic pH in vascular smooth
muscle cells, are involved in acidosis-induced coronary arteriolar
dilation [60,61]. Recent studies indicate that extracellular acidosis
activates acid-sensing ion channels (ASIC) to regulate the function
of smooth muscle cells [62]. We have recently shown that
extracellular acidosis activates GPR4 in endothelial cells and leads
to cAMP production and the inhibition of endothelial cell
migration and microvessel growth [15], suggesting that GPR4 is
a functional pH sensor in endothelial cells.
In this report, we have identified a novel function of the GPR4
receptor. Activation of GPR4 by acidosis enhances HUVEC
adhesiveness and binding with U937 monocytes. This effect is
augmented by GPR4 overexpression and diminished by GPR4
knockdown in HUVECs. Since the interaction between endothe-
lial cells and leukocytes is critical for inflammatory response,
acidosis/GPR4 signaling may represent a new pathway in
inflammation. With particular relevance, local interstitial acidosis
is commonly found in inflammatory tissues. For instance, acidic
tissue pH is associated with asthma, arthritis, and cystic fibrosis
[2,4,6]. Acidosis is also frequently identified in ischemia and solid
Figure 7. Blockade of E-selectin, VCAM-1 or ICAM-1 reduces
the adhesion of HUVECs with U937 monocytic cells. HUVECs
stably overexpressing GPR4 were treated with different pHs as indicated
for 5 to 15 h, followed by 30 min incubation with pH 7.4 medium
containing 5 mg/ml IgG1 control antibody, anti-E-selectin, anti-VCAM-1,
or anti-ICAM-1 antibody. The cell adhesion assay was then performed as
described under ‘‘Materials and Methods’’. **, P,0.01; ***, P,0.001;
compared with the IgG1 control group at pH 6.4. The results are
representative of two independent experiments. Error bars are the
mean 6 SEM.
doi:10.1371/journal.pone.0027586.g007
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tumors in which inflammation plays an important role in disease
progression. Interestingly, it has been shown that inflammatory
stimuli TNF-a and H2O2 can induce GPR4 mRNA expression in
human brain microvascular endothelial cells but not dermal
microvascular endothelial cells [63]. These data suggest that the
acidosis/GPR4 pathway may serve as a potential target for
modulating vascular adhesion, endothelium-blood cell interaction,
and inflammatory responses.
Acidosis can modulate the expression of a wide range of genes in
various cell systems such as renal, intestinal, and cancer cells
[64,65,66]. Previous studies showed that acidosis is important for
hypoxia/inflammatory stimuli-induced ICAM-1 expression in
cultured endothelial cells [67]. Acidification of extracellular pH
increases the expression of a key inflammatory enzyme cycloox-
ygenase-2 (COX-2) in endothelial cells [68]. However, the pH-
sensing mechanisms of endothelial cells in response to acidosis are
Figure 8. Activation of GPR4 by hypercapnic acidosis stimulates HUVEC adhesion molecule expression, cAMP production, and
adhesiveness. (A–C) HUVEC/Vector, HUVEC/GPR4, or HUVEC/GPR4 R115A cells were treated with ambient air, 5% CO2, or 20% CO2-buffered EGM-2
pH media for 5 h. Total RNA was isolated and mRNA levels of E-selectin (A), VCAM-1 (B), and ICAM-1 (C) were determined by real-time RT-PCR. Values
were normalized to the housekeeping gene GAPDH. The expression level of the target gene in HUVEC/Vector cells under ambient air (,pH 8.4) was
set as 1. (D) The intracellular cAMP level in HUVEC/Vector and HUVEC/GPR4 cells treated with the CO2-buffered pH media was determined by the
cAMP assay as described in the ‘‘Materials and Methods’’. *, P,0.05; **, P,0.01; compared with the 5% CO2 group. (E) HUVEC/Vector and HUVEC/
GPR4 cells were treated with the CO2-buffered pH media as indicated for 5 h. The cell adhesion assay was performed as described in the ‘‘Materials
and Methods’’. ***, P,0.001; compared with the 5% CO2 group. All the above results are representative of at least two independent experiments.
Error bars are the mean 6 SEM.
doi:10.1371/journal.pone.0027586.g008
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not well defined. Our results suggest that GPR4 is a novel sensor
for vascular endothelial cells to respond to acidic tissue
microenvironments and elicit inflammatory responses. Data
presented here reveal that acidosis activates GPR4 to increase
endothelial cell adhesiveness through multiple adhesion molecules
such as E-selectin, VCAM-1, and ICAM-1, which then facilitate
the binding of leukocytes.
We have also shown that hypercapnic acidosis, similar as
isocapnic acidosis, can activate GPR4 to increase the expression of
adhesion molecules and the adhesive capacity of HUVECs. In the
literature, there are seemingly conflicted reports regarding the
effects of hypercapnia on endothelial cell adhesion. Takeshita et al.
showed that hypercapnia decreased the lipopolysaccharide (LPS)-
induced upregulation of ICAM-1 in human pulmonary artery
endothelial cells [69]. However, Liu et al. recently demonstrated
that hypercapnia increased the LPS-induced expression of
inflammatory molecules such as ICAM-1, VCAM-1 and E-
selectin in human pulmonary microvascular endothelial cells and
in a LPS-induced lung injury animal model [70]. Our own results
using HUVECs as a model system are in line with the observations
by Liu et al. [70] but in contrast to the reports by Takeshita et al.
[69]. Although the reasons for the paradoxical findings are not
exactly clear, the use of endothelial cells from different vessel types
has been proposed as a potential explanation [70]. Indeed,
endothelial cells isolated from different types of blood vessels have
been shown to exhibit different phenotypes, gene expression
profiles and responses to stimuli [71,72]. It should also be noted
that hypercapnia leads to the increase of not only protons but also
carbon dioxide and bicarbonate, all of which can trigger
downstream signaling pathways through different mechanisms
[11]. Thus, hypercapnia may elicit more complicated biological
effects than hypercapnic acidosis alone. In the HUVEC model
system, our results strongly suggest that hypercapnic acidosis can
activate the proton-sensing receptor GPR4 in a gene dose-
dependent manner. This observation may have implications in
certain hypercapnia-associated clinical problems. For instance, the
low-tidal-volume mechanical ventilation, used for the treatment of
acute lung injury (ALI) and acute respiratory distress syndrome
(ARDS), commonly causes hypercapnia [73]. While some studies
indicate that hypercapnia is potentially beneficial in attenuating
lung inflammation during ventilation, other studies suggest the
opposite [9,69,70,74,75]. These observations underscore the
complex biological effects of hypercapnia and the importance of
further research to better understand the manifold pro- and anti-
inflammatory signaling pathways related to hypercapnia. In this
regard, GPR4 signaling may represent a novel pathway that senses
hypercapnic acidosis and modulates inflammatory responses.
Moreover, we have further demonstrated that G protein
signaling and the Gs/adenylate cyclase/cAMP/Epac pathway
are important for acidosis/GPR4-induced HUVEC adhesion.
This conclusion is supported by several lines of evidence. First, the
R115A DRY motif mutant of GPR4, which is deficient in G
protein signaling, fails to increase HUVEC adhesiveness in
response to acidosis. Second, inhibition of adenylate cyclase or
Epac substantially blunts the acidosis/GPR4-induced HUVEC
adhesion. Third, treatment with the cAMP analog 8-bromo-
cAMP or the Epac specific activator 8-CPT-2Me-cAMP recapit-
ulates the HUVEC adhesive phenotype induced by acidosis/
GPR4 signaling. Our observations are in line with several previous
studies. Rangarajan et al. demonstrate that upon the stimulation of
b2-adrenergic receptor, cAMP induces the adhesion of Ovcar3
ovarian cancer cells through the Epac/Rap1 pathway [34].
Fukuhara et al. show that the cAMP/Epac pathway increases
VE-cadherin-mediated cell-cell contact and promotes endothelial
barrier function [76]. Our results indicate that the Gs/cAMP/
Epac pathway is also involved in acidosis/GPR4-induced
endothelial cell adhesion, illustrating a recurrent theme in
signaling transduction that diverse stimuli and receptor activation
may converge into common downstream signaling pathways. It
should also be pointed out that activation of GPR4 by acidosis has
been shown to stimulate multiple G protein pathways including
Gs, Gq and G13, of which the physiological role of Gq and G13
pathways in endothelial cell acidosis responses is not clear and
needs to be further studied.
Emerging evidence suggests that the GPR4 family of proton-
sensing GPCRs, including GPR4, TDAG8, OGR1 and G2A,
plays a role in inflammation. Previous studies have demonstrated
that acidosis activates TDAG8 to produce cAMP in thymocytes
and splenocytes [19,77]. Stimulation of TDAG8 by acidosis
regulates the viability of eosinophils and the production of
cytokines [78,79]. Our results show that activation of GPR4 by
acidosis increases the adhesiveness of endothelial cells. While we
have not studied the effects of acidosis/GPCR signaling on
leukocyte adhesiveness, this aspect warrants further investigation
because the reciprocal interaction between endothelial cells and
leukocytes is critical for inflammation. Current data indicate that
the proton-sensing GPCRs, such as GPR4 and TDAG8,
potentially serve as the pH sensors for vascular cells and blood
cells to perceive the acidic microenvironment at inflammatory sites
and transduce signaling pathways to regulate the function of blood
vessels and leukocytes. As acidosis is closely associated with
inflammation, ischemia, cancer, and other diseases, the GPR4
proton-sensing receptor family may play a role in these
pathological conditions.
Supporting Information
Figure S1 Acidosis/GPR4-induced HUVEC adhesion
using different types of culture media or leukocytes.
(A) HUVEC/Vector and HUVEC/GPR4 cells were treated with
EGM-2/HEM media at indicated pHs for 5 to 15 h. RPMI
medium supplemented with 10% FBS was used to replace DMEM
medium for growing U937 cells and washing the plate to remove
non-adhered U937 cells. The cell adhesion assay was performed as
described in the ‘‘Materials and Methods’’. **, P,0.01; compared
with the pH 8.4 group. (B) HUVEC/Vector and HUVEC/GPR4
cells were treated with EGM-2/HEM media at different pHs as
indicated for 5 to 15 h. Afterwards, 66104 cells/well of HL-60
promyelocytic cells were added to adhere with HUVECs for 1 h at
pH 7.4, and the cell adhesion assay was performed. **, P,0.01;
***, P,0.001; compared with the pH 8.4 group. The results are
representative of two or more independent experiments. Error bars
are the mean 6 SEM.
(TIF)
Figure S2 Endogenous mRNA level of GPR4 in HUVECs
is decreased during acidic pH treatment. HUVEC/Vector
cells were treated with EGM-2/HEM media at pH 8.4, 7.4 or 6.4
pH for 5 h. Total RNAs were isolated and the level of GPR4
mRNA was determined by real-time RT-PCR. Values were
normalized to the housekeeping gene GAPDH. The expression
level of GPR4 at pH 8.4 was set as 1. Error bars are the mean 6
SEM. ***, P,0.001; compared with pH 8.4.
(TIF)
Figure S3 Correlation between the intensity of GFP
signal and the adhesiveness of HUVEC cells. In HUVEC/
GPR4 cells, GPR4 was co-expressed with a bicistronic GFP
marker, which can serve as an indicator of GPR4 expression.
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HUVEC/GPR4 cells were treated with EGM-2/HEM medium at
pH 6.4 for 5 h. The cell adhesion assay was performed as
described under ‘‘Materials and Methods’’. After the adhesion
assay, HUVEC/GPR4 cells and attached U937 cells were
detected under an inverted fluorescence microscope (Zeiss) with
a 106objective. Micrographs of phase contrast (A) or GFP signal
(B) of cells in the same field were taken and compared. In the
phase contrast picture (A), the large and flat cells were HUVECs
and the small, round and reflectile cells were attached U937 cells.
Arrows indicate the areas with U937 cell attachment in the phase
contrast picture (A) and the corresponding GFP signal of
HUVECs in the fluorescence picture (B).
(TIF)
Figure S4 P-selectin mRNA expression and protein
translocation are not affected by acidosis/GPR4 in
HUVECs. (A) HUVEC/Vector, HUVEC/GPR4, and HU-
VEC/GPR4 R115A cells were treated with EGM-2/HEM media
at pH 8.4, 7.4 or 6.4 for 5 h. Total RNA was isolated and mRNA
levels of P-selectin were determined by real-time RT-PCR. Values
were normalized to the housekeeping gene GAPDH. The
expression level of P-selectin at pH 8.4 was set as 1. The results
are representative of two independent experiments. Error bars are
the mean 6 SEM. (B) HUVEC/Vector and HUVEC/GPR4 cells
were treated with EGM-2/HEM media at pH 8.4, 7.4, or 6.4 for
5 h, or with EGM-2 medium containing 10 nM thrombin for
20 min. After the treatment, cells were fixed with 100% methanol,
incubated with P-selectin primary antibody, Rhodamine Red-
conjugated secondary antibody, and then detected under a
fluorescence microscope (1006 objective). Thrombin treatment
served as the positive control for P-selectin translocation. Weibel-
Palade (WP) bodies that contain P-selectin are shown as bright
particles indicated by short arrows. The translocation of WP
bodies from cytoplasm to cell membrane is indicated by solid
arrows in the thrombin treatment groups. The results are
representative of three independent experiments.
(TIF)
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